Imagine a world where it is possible to constantly monitor heart health without visiting a hospital, where individuals with heart failure or hypertension receive real-time information on their hearts ...
In 2024, medtech IPOs began to come back, thanks to the likes of heart valve company Anteris Technologies and neurotech ...
Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.
Zoll announced today that it launched its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the U.S.
Bhopal: Heart patients will no longer need to undergo catheter-based angiography, as Hamidia Hospital is set to introduce cardiac MRI structure and function comparable to conventional angiography, ...
Everyday Health on MSN
Can Wearable Devices Help Prevent Heart Disease?
Smartwatches and wearable heart monitors can help detect issues such as irregular heart rhythms. But they also have limits ...
Medical Device Network on MSN
ZOLL introduces next-gen wearable cardioverter defibrillator in US
Medical devices and related software solutions maker ZOLL has introduced its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the US. The latest device is the fifth LifeVest WCD, ...
Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing technologies Alliance positions INBS to ...
Reduced coronary blood flow, measured with an artificial intelligence-based imaging tool, predicted future cardiovascular events in patients with suspected stable coronary artery disease. These ...
LBA-5: A hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery: The TRACTION trial ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- When hospitals were randomly assigned to ...
A noninvasive method for measuring blood glucose levels, developed at MIT, could save diabetes patients from having to prick their fingers several times a day. The MIT team used Raman spectroscopy — a ...
(ORLANDO, Dec. 9, 2025) –– When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) or a placebo, patients who received TXA needed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback